Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Saini, Kamal S., Lanza, Carlo, Romano, Marco, de Azambuja, Evandro, Cortes, Javier, de las Heras, Begoña, de Castro, Javier, Lamba Saini, Monika, Loibl, Sibylle, Curigliano, Giuseppe, Twelves, Chris, Leone, Manuela, Patnaik, Mrinal M.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Comment
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7307309/
https://ncbi.nlm.nih.gov/pubmed/32572174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0948-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados